OBJECTIVE: To compare new bone formation in maxillary sinus augmentation procedures using biomaterial associated with mesenchymal stem cells (MSCs) separated by two different isolation methods. BACKGROUND: In regenerative medicine open cell concentration systems are only allowed for clinical application under good manufacturing practice conditions. METHODS: Mononuclear cells, including MSCs, were concentrated with either the synthetic polysaccharide (FICOLL) method (classic open system--control group, n = 6 sinus) or the bone marrow aspirate concentrate (BMAC) method (closed system--test group, n = 12 sinus) and transplanted in combination with biomaterial. A sample of the cells was characterized by their ability to differentiate. After 4.1 months (SD +/- 1.0) bone biopsies were obtained and analyzed. RESULTS: The new bone formation in the BMAC group was 19.9% (90% confidence interval [CI], 10.9-29), and in the FICOLL group was 15.5% (90% CI, 8.6-22.4). The 4.4% difference was not significant (90% CI, -4.6-13.5; p = 0.39). MSCs could be differentiated into osteogenic, chondrogenic, and adipogenic lineages. CONCLUSION: MSCs harvested from bone marrow aspirate in combination with bovine bone matrix particles can form lamellar bone and provide a reliable base for dental implants. The closed BMAC system is suited to substitute the open FICOLL system in bone regeneration procedures.
OBJECTIVE: To compare new bone formation in maxillary sinus augmentation procedures using biomaterial associated with mesenchymal stem cells (MSCs) separated by two different isolation methods. BACKGROUND: In regenerative medicine open cell concentration systems are only allowed for clinical application under good manufacturing practice conditions. METHODS: Mononuclear cells, including MSCs, were concentrated with either the synthetic polysaccharide (FICOLL) method (classic open system--control group, n = 6 sinus) or the bone marrow aspirate concentrate (BMAC) method (closed system--test group, n = 12 sinus) and transplanted in combination with biomaterial. A sample of the cells was characterized by their ability to differentiate. After 4.1 months (SD +/- 1.0) bone biopsies were obtained and analyzed. RESULTS: The new bone formation in the BMAC group was 19.9% (90% confidence interval [CI], 10.9-29), and in the FICOLL group was 15.5% (90% CI, 8.6-22.4). The 4.4% difference was not significant (90% CI, -4.6-13.5; p = 0.39). MSCs could be differentiated into osteogenic, chondrogenic, and adipogenic lineages. CONCLUSION: MSCs harvested from bone marrow aspirate in combination with bovine bone matrix particles can form lamellar bone and provide a reliable base for dental implants. The closed BMAC system is suited to substitute the open FICOLL system in bone regeneration procedures.
Authors: Sonia Egido-Moreno; Joan Valls-Roca-Umbert; Juan Manuel Céspedes-Sánchez; José López-López; Eugenio Velasco-Ortega Journal: Int J Environ Res Public Health Date: 2021-01-21 Impact factor: 3.390
Authors: Marcelo de Oliveira E Silva; André Antonio Pelegrine; Alexandre Alves Pinheiro da Silva; Luiz Roberto Manhães Júnior; Rafael de Mello E Oliveira; Silvana Gaiba França; Antonio Carlos Aloise; Lydia Masako Ferreira Journal: Int J Biomater Date: 2012-08-29
Authors: Miguel Padial-Molina; Francisco O'Valle; Alejandro Lanis; Francisco Mesa; David M Dohan Ehrenfest; Hom-Lay Wang; Pablo Galindo-Moreno Journal: Biomed Res Int Date: 2015-05-12 Impact factor: 3.411
Authors: Paulo José Pasquali; Marcelo Lucchesi Teixeira; Thiago Altro de Oliveira; Luis Guilherme Scavone de Macedo; Antonio Carlos Aloise; André Antonio Pelegrine Journal: Int J Biomater Date: 2015-10-12
Authors: Fabian Duttenhoefer; Stefan F Hieber; Andres Stricker; Rainer Schmelzeisen; Ralf Gutwald; Sebastian Sauerbier Journal: Biores Open Access Date: 2014-04-01